Biotech Archives - Page 12 of 795

1 minute read

IMCC Reports Accelerated Growth In Germany Through New Supply Agreement With EU-GMP Certified Glasshouse Botanics

June 5, 8:33 AM

IMC Germany's accelerated growth potential leans strongly on its supply strategy through its ability to partner with cannabis growers for EU-GMP certification, bolstering the company's supply chain with exclusive

CSE:IMCC

1 minute read

Nanox Launches AI Functionality In Second Opinions Online Medical Consultation Service

By Benzinga Newsdesk

June 5, 8:24 AM

Nanox integrates FDA-cleared population health AI solutions into its Second Opinions service New AI capabilities available to patients who submit chest and abdominal CT scans for second opinionsOffering the power

NNOX

1 minute read

Amneal Expands Broad Injectables Portfolio With The Addition of Six New Product Launches

By Benzinga Newsdesk

June 5, 8:14 AM

Amneal's Q2 2024 injectable product launches: Product launchDosage formASHP drug shortage1PEMRYDI RTU®VialNo2Atropine sulfatePrefilled syringeYes3DocetaxelInjectionYes4FoscarnetIV bagNo5Methylprednisolone

AMRX

1 minute read

Arcutis Reports Multiple Abstracts, Including Oral Presentation At The Revolutionizing Alopecia Areata, Vitiligo, And Eczema Conference From June 8-10, 2024

By Benzinga Newsdesk

June 5, 8:07 AM

New long-term safety and efficacy data of investigational roflumilast cream 0.15% in mild to moderate atopic dermatitis will be presented in an oral session Preclinical data on ARQ-234, CD200R agonist, for the

ARQT

2 minute read

EXCLUSIVE: Adial Pharmaceuticals Starts Patient Dosing In Pharmacokinetics Study Of AD04 For Alcohol Use Disorder

By Vandana Singh

June 5, 8:00 AM

Adial Pharmaceuticals starts dosing in pharmacokinetics study of AD04 for Alcohol Use Disorder in heavy drinking patients. Topline results in early Q4 2024.

ADIL

1 minute read

MangoRx Gets Patent Notice Of Allowance In Japan For Revolutionary Preventive Care Technology

By Benzinga Newsdesk

June 4, 4:00 PM

Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling a variety of men's health and wellness products in the area of erectile dysfunction (ED), hair

MGRX

2 minute read

National Institutes of Health Kickstarts Gilead Sponsored Trials For Twice-Yearly HIV Prevention Injection

By Vandana Singh

June 4, 3:57 PM

The US National Institutes of Health has launched two clinical trials to test a new long-acting form of HIV PrEP in cisgender women and people who inject drugs. These mid-stage studies will evaluate the safety and pharmacokinetics of lenacapavir, a bi-annual injectable antiretroviral drug.

GILD

1 minute read

BridgeBio Pharma Shares One Year Data From Dwarfism Candidate

By Vandana Singh

June 4, 3:29 PM

BridgeBio Pharma revealed results from the PROPEL 2 Phase 2 trial of infigratinib in children with achondroplasia. Key data shows sustained increases in height velocity and improved body proportionality with a good safety profile.

BBIO

2 minute read

Sanofi Highlights Data From Blood Cancer Drug Sarclisa In New Diagnosed Multiple Myeloma Patients

By Vandana Singh

June 4, 3:18 PM

Sanofi's phase 3 IMROZ study shows Sarclisa with VRd significantly improves progression-free survival in newly diagnosed, transplant-ineligible multiple myeloma patients.

SNY

3 minute read

Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon

By Upwallstreet

June 4, 1:45 PM

On Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial. On Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE:

MRK